Elephas Biosciences Corp Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2020

Location

Madison WI US

Primary Industry

Biotechnology

About

Based in Wisconsin, US, and founded in 2020 by its CEO Maneesh Arora and CSO Jonathan D. Oliner, Elephas Biosciences Corp. operates as a developer and provider of biotechnology imaging platforms to help in diagnostics and novel pharmaceutical therapies. In November 2023, Elephas Biosciences Corp. raised USD 51.22 million in series C funding co-led by investors State of Wisconsin Investment Board, Venture Investors, WARF Ventures, Tao Capital Partners, Moore Strategic Ventures, Sands Capital Ventures, ARCH Venture Partners, and Northpond Ventures. Elephas Biosciences Corp. offers an oncology diagnostics platform that utilizes live fragments from a patient biopsy and treats those fragments with potential therapies and combinations. The company's CybridTM platform incorporates a comprehensive suite of assays to help understand the mechanisms of action of immunotherapeutic compounds indicating drug response, and it also provides insights into cancer treatment decisions and accelerates immuno-oncology drug development. The company plans to use the November 2023 funding to support building its platform.

Current Investors

ARCH Venture Partners, Tao Capital Partners, Sands Capital Ventures

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Oncology/Cancer Treatment, Diagnostic Equipment, Pharmaceutical Research & Development

Website

www.elephas.com

Verticals

Artificial Intelligence, HealthTech

Company Stage

Series C

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.